FU Zu-zhi

962 citations
14 papers · 161 indexed · h-index 6
Topics
Adipokines, Inflammation, and Metabolic Diseases (4 papers)Adipose Tissue and Metabolism (3 papers)Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers)
Partner nations
China

In The Last Decade

FU Zu-zhi

14 papers receiving 154 citations

Peers

FU Zu-zhi
Comparison fields: 5 of 43
  • Molecular Biology 73
  • Endocrinology, Diabetes and Metabolism 66
  • Cancer Research 49
  • Surgery 37
  • Physiology 24
Replace Liuqing Xi with:
Liuqing Xi China
Zhengping Feng China
Ekaterina А. Shestakova Russia
Xinrui Tan China
Liisa Hakaste Finland
Regina Cole United States
Martin Muurling Netherlands
Diego Bailetti Italy
Shih‐Che Hua Taiwan
Chongbo Yang China
FU Zu-zhi relative to Liuqing Xi China Liuqing Xi's profile →
Citations per field
00.5×1.5×
Liuqing Xi · 1×
Citations per year

Countries citing papers authored by FU Zu-zhi

Since Specialization
Citations

This map shows the geographic impact of FU Zu-zhi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by FU Zu-zhi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites FU Zu-zhi more than expected).

Fields of papers citing papers by FU Zu-zhi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by FU Zu-zhi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by FU Zu-zhi. The network helps show where FU Zu-zhi may publish in the future.

Co-authorship network of co-authors of FU Zu-zhi

This figure shows the co-authorship network connecting the top 25 collaborators of FU Zu-zhi. A scholar is included among the top collaborators of FU Zu-zhi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with FU Zu-zhi. FU Zu-zhi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1
Effects of Angiotensin on Increased Body Weight and Dyslipidemia Induced by High-Fat Diet in Rats
1
2 17
3 4
4
miR-375 enhances palmitate-induced lipoapoptosis in insulin-secreting NIT-1 cells by repressing myotrophin (V1) protein expression.
61
5
[Insulin resistance and islet beta cell function in type 2 diabetes mellitus and non alcoholic fatty liver disease.].
2
6 8
7 1
8 6
9 5
10
Progress in resistin and type 2 diabetes as well as obesity
1
11
Ten-years Studies on Diabetes Mellitus (1992-2001)
1
12 43
13
[Association of the cocaine and amphetamine-regulated transcript gene with type 2 diabetes mellitus].
8
14
[Antigen transporter gene polymorphism and predisposition to Graves disease: a preliminary analysis].
3

About FU Zu-zhi

FU Zu-zhi is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Physiology, having authored 14 papers that have together received 161 indexed citations. Recurring topics across this work include Adipokines, Inflammation, and Metabolic Diseases (4 papers), Adipose Tissue and Metabolism (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (66 citations), Cancer Research (49 citations) and Endocrine and Autonomic Systems (11 citations). FU Zu-zhi has collaborated with scholars based in China. Frequent co-authors include Hua Cheng, Shanying Liu, Feng Li, Xuejuan Xu, Ying Liang, Yan Li, Yan Gao, Jiawei Chen, Changyu Pan and Juming Lu. Their work appears in journals such as Diabetes Research and Clinical Practice, Current Medical Research and Opinion and Chinese Medical Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026